GSK3A and neuroblastoma: Treatment of neuroblastoma cells with CHIR99021 for 24h resulted in a significant decrease in the abundance of GSK3α and β isoforms in addition to an increase in their phosphorylation, consistent with a reduction in GSK3 activity (Fig. 3c–e).